查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971699

动物病毒检测试剂盒市场：按技术、动物类型、检体类型、病毒类型、最终用户和分销管道划分－全球预测，2026-2032年

Animal Virus Detection Kit Market by Technology, Animal Type, Sample Type, Virus Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

动物病毒检测试剂盒市场预计到 2025 年将达到 15.5 亿美元，到 2026 年将成长到 17.1 亿美元，到 2032 年将达到 32.7 亿美元，复合年增长率为 11.28%。

主要市场统计数据
基准年 2025 15.5亿美元
预计年份：2026年 17.1亿美元
预测年份：2032年 32.7亿美元
复合年增长率 (%) 11.28%

针对不同兽医和监测生态系统中动物病毒诊断试剂盒的创新和部署，制定迫切的策略框架。

目前动物病毒检测试剂盒的发展正处于技术创新、公共卫生紧迫性和产业转型三者交会的阶段。对快速检测、早期控制和跨动物及人类健康领域的综合监测的需求，正迅速推动诊断能力从以往局限于中心实验室转向可现场部署的形式。随着病原体的不断出现和再次出现，从兽医诊所到研究机构的相关人员必须应对复杂的平台、检体类型和法规环境，才能有效控制疾病并保障供应链安全。

技术突破和营运创新如何迅速重新定义动物健康领域诊断性能的预期和部署策略？

近年来，一系列变革正在改变动物病毒检测试剂盒的研发、检验和应用方式。分子生物学的进步，特别是基于CRISPR的诊断技术的成熟和等温扩增技术的改进，降低了高灵敏度和快速检测的技术门槛，使得在远离集中式参考实验室的情况下进行分散式检查成为可能。同时，新一代定序平台变得更加普及和柔软性，能够实现对病原体的全面监测和对新型变异株的快速鑑定。这为诊断设计和疫情应对提供了宝贵的资讯。

评估美国关税调整对动物诊断试剂盒采购和商业化的广泛供应链、定价和策略影响。

改变跨境贸易动态的政策变化将对动物病毒检测试剂盒的供应链和商业策略产生直接而显着的影响。美国在2025年实施的关税调整迫使製造商和经销商重新评估其筹资策略、製造地和定价模式。这些变化凸显了本地生产能力和战略储备的重要性日益增加，它们是缓解进口成本波动、确保酵素、试剂盒和试剂等关键诊断材料持续供应的有效手段。

以市场区隔主导导向的综合产品策略和市场推出方法，整合技术、动物类型、检体物流和分销管道，以实现成功的诊断。

了解细分市场的细微差别对于研发和销售部门至关重要，这有助于他们将产品功能与最终用户需求和实际营运状况相匹配。从技术角度来看，这包括：基于 CRISPR 的方法，使用 Cas12/Cas13 变体，兼具高特异性和快速侧向流动整合的潜力；竞争性、间接和夹心式酵素免疫分析法，它们仍然是抗原和抗体检测的基础；恒温环型核酸扩增平台，包括侧向流动 LAMP 和实时LAMP，无需复杂的热迴圈仪即可实现现场扩增；下一代定序技术，分为长读长和短读长策略，既可用于全面的病原体发现，也可用于靶向监测；以及聚合酵素链锁反应平台，分为数位 PCR 和即时PCR，它们不断树立分析灵敏度的新标准。

全球兽医市场中部署模式和基础设施的区域差异决定了检验通路、分销模式和监测合作。

区域趋势正在塑造不同的技术采纳曲线、监管预期和供应链韧性，这需要企业认真考虑。在美洲，成熟的检查室网路、健全的兽医基础设施和一体化的供应链促进了高通量平台和检验检测组合的采用，而偏远的农业地区则同时需要照护现场解决方案。在欧洲、中东和非洲，监管的多样性和检测能力的差异为灵活的检验策略和模组化平台提供了机会，这些策略和平台可以适应当地的核准流程和资源限制。此外，这些地区内不同的农业实践凸显了对高度适应性的检体采集方法和培训计划的需求。

结合快速检测创新、严格的检验方法、可扩展的生产系统和促进应用的伙伴关係生态系统，形成竞争优势。

该领域的竞争动态更取决于能否将技术创新与实际检验、清晰的监管框架以及可靠的供应链相结合，而非单纯的规模优势。主要企业展现出在保持快速的检测方法开发、可靠的分析和临床检验以及严格的品管的同时，实现规模化生产的能力。检测开发公司、仪器製造商和分销商之间的合作十分普遍，透过整合试剂盒和耗材、仪器以及数位化报告工具，能够更快地进入市场并提供更广泛的服务。

为了将诊断技术的创新转化为在各种环境下稳健的供应模式、快速检验和最终用户的可持续采用，企业必须实施可操作的策略措施。

产业领导者应优先采取一系列具体行动，将技术潜力转化为可持续的实际应用效果。首先，投资支援多种检测化学方法的模组化平台，可以缩短新产品上市时间，并为客户提供面向未来的解决方案。其次，建构区域性生产和分销冗余体系，可以降低关税导致的成本飙升和供应中断风险，同时透过有针对性的库存策略确保关键试剂的持续供应。第三，透过系统性的现场测试和第三方评估加快检验，可以增强诊断实验室和大型生产商的信心，并缩短采购週期。

为了支持实际见解，我们采用稳健的混合方法研究途径，结合专家访谈、综合技术检验、供应链映射和监管分析。

本分析所依据的研究结合了结构化的一手和二手研究，以确保其兼具深度和实用性。一手研究包括对兽医诊断专家、检查室经理、农场经理和研发负责人进行访谈，以了解最终用户的优先事项、检验挑战和采购偏好。这些定性研究结果与通讯协定审查、同行评审文献和监管指南进行三角验证，从而确定技术成熟度等级和检验要求。透过对检测检验研究和仪器规格的综合分析，评估了技术性能属性，以评估其在各种检体类型和使用情境中的适用性。

我们综合考虑了诊断效能、供应链韧性和相关人员合作，作为决定动物健康监测未来成功的关键因素。

病原体出现、技术进步和贸易格局变化带来的多重压力，要求诊断试剂开发商、经销商和终端用户通力合作。动物病毒检测试剂盒领域的成功取决于能否提供分析性能可靠且适用于各种检体基质和终端用户环境的操作性检测方法。同样重要的是建立具有韧性的价值炼和适应性强的商业策略，以应对政策变化和区域差异。结合严格的现场检验和针对性培训，这些要素能够创造极具吸引力的价值提案，从而加速产品应用并加强监测系统。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：动物病毒检测试剂盒市场：依技术分类

  • CRIPR 基地
    • Cas12
    • Cas13
  • 酵素免疫分析法
    • 竞争对手
    • 间接法
    • 三明治法
  • 恒温环型核酸扩增法
    • 侧向流动灯
    • 实时 LAMP
  • 下一代定序
    • 长週期
    • 短线
  • 聚合酵素链锁反应
    • 数位PCR
    • 即时PCR

第九章：动物病毒检测试剂盒市场：依动物类型划分

  • 水产养殖
    • 鱼
    • 虾
  • 伴侣动物
    • 猫
    • 狗
  • 家畜
    • 牛
    • 羊
    • 猪
  • 家禽
    • 鸡
    • 鸭子
    • 火鸡

第十章：动物病毒检测试剂盒市场：依检体类型划分

  • 血
    • 电浆
    • 血清
    • 全血
  • 屎
  • 拭子
    • 鼻腔
    • 口服
    • 直肠
  • 组织

第十一章：动物病毒检测试剂盒市场：依病毒类型划分

  • DNA
    • 信封类型
    • 非信封式
  • RNA
    • 信封类型
    • 非信封式

第十二章：动物病毒检测试剂盒市场：依最终用户划分

  • 诊断实验室
    • 私人考试机构
    • 公共卫生实验室
  • 农场
  • 研究机构
  • 动物医院

第十三章：动物病毒检测试剂盒市场：依通路划分

  • 直销
  • 销售代理
  • 线上平台

第十四章：动物病毒检测试剂盒市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：动物病毒检测试剂盒市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：动物病毒检测试剂盒市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国动物病毒检测试剂盒市场

第十八章：中国动物病毒检测试剂盒市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Heska Corporation
  • Luminex Corporation
  • Merck KGaA
  • Neogen Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-2B5802CFE8EA

The Animal Virus Detection Kit Market was valued at USD 1.55 billion in 2025 and is projected to grow to USD 1.71 billion in 2026, with a CAGR of 11.28%, reaching USD 3.27 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.55 billion
Estimated Year [2026] USD 1.71 billion
Forecast Year [2032] USD 3.27 billion
CAGR (%) 11.28%

Framing the urgent strategic context for animal virus diagnostic kit innovation and deployment across diverse veterinary and surveillance ecosystems

The animal virus detection kit landscape now sits at the intersection of technological innovation, public health urgency, and sectoral transformation. Diagnostic capabilities that were once confined to centralized laboratories are rapidly migrating toward field-deployable formats, driven by the need for faster detection, early containment, and integrated surveillance across animal and human health domains. As pathogens continue to emerge and re-emerge, stakeholders from veterinary clinics to research institutes must navigate a complex array of platforms, sample types, and regulatory environments in order to maintain effective disease control and safeguard supply chains.

Adoption drivers include the push for rapid point-of-care diagnostics, the proliferation of multiplex and high-sensitivity assays, and growing expectations for interoperability with digital health infrastructure. At the same time, end users face constraints related to sample logistics, cold chain management, and variable laboratory capacity, which emphasize the need for robust, user-friendly kits that perform reliably across diverse settings. In this context, the industry's strategic choices around technology selection, distribution models, and validation pathways will determine which solutions achieve sustained adoption and deliver measurable impact on animal health outcomes.

How converging technological breakthroughs and operational innovations are rapidly redefining diagnostic performance expectations and deployment strategies in animal health

Recent years have delivered a set of transformative shifts that are reshaping how animal virus detection kits are developed, validated, and deployed. Advances in molecular biology, particularly the maturation of CRISPR-based diagnostics and improvements in isothermal amplification techniques, have lowered the technical threshold for highly specific, rapid assays, enabling decentralization of testing away from centralized reference labs. Concurrently, next generation sequencing platforms have become more accessible and flexible, allowing for comprehensive pathogen surveillance and the rapid characterization of novel variants, which informs both diagnostic design and outbreak response.

Operationally, there is a clear pivot toward integrated diagnostic workflows that link sample collection, in-field testing, and cloud-based data aggregation to support real-time decision-making. This trend is reinforced by investments in automation, digital result reporting, and AI-enabled analytics that improve interpretation and trend detection. Regulatory frameworks are also evolving to accommodate emergency use pathways and pragmatic validation strategies, which accelerates time-to-adoption for novel assays while emphasizing the need for robust clinical evidence. Taken together, these shifts favor diagnostic solutions that balance analytical performance with ease of use, supply chain resilience, and seamless data integration across public health and veterinary networks.

Evaluating the wide-ranging supply chain, pricing, and strategic consequences of U.S. tariff policy adjustments on animal diagnostic kit sourcing and commercialization

Policy changes that alter cross-border trade dynamics have a direct and consequential impact on the animal virus detection kit supply chain and commercial strategies. Tariff adjustments implemented by the United States in 2025 have prompted manufacturers and distributors to reassess sourcing strategies, manufacturing footprints, and pricing models. These changes increase the salience of local production capabilities and strategic stockpiling as mechanisms to mitigate import cost volatility and ensure continuity of supply for critical diagnostic inputs such as enzymes, cartridges, and reagents.

In response, many stakeholders have accelerated localization efforts, diversified supplier relationships, and negotiated longer-term contracts to buffer against tariff-driven cost fluctuations. For research-oriented organizations and smaller suppliers, elevated import costs can constrict margins and slow the pace of field validation studies unless offset by operational efficiencies or new funding sources. Conversely, distributors and end users have shown increased interest in bundled services and integrated supply agreements that stabilize procurement. Overall, the tariff environment has reinforced the need for flexible manufacturing strategies, transparent cost modeling, and proactive regulatory engagement to preserve affordability and access to high-quality diagnostic kits.

Comprehensive segmentation-driven product and go-to-market imperatives that align technology, animal species, sample logistics, and distribution pathways for diagnostic success

A nuanced understanding of segmentation is essential for developers and commercial teams to align product features with end-user needs and operational realities. Across technology, options span CRISPR-based approaches with Cas12 and Cas13 variants that offer high specificity and potential for rapid lateral-flow integrations; enzyme-linked immunosorbent assays available in competitive, indirect, and sandwich formats that remain foundational for antigen and antibody detection; loop mediated isothermal amplification platforms including lateral flow LAMP and real-time LAMP that support field-friendly amplification without complex thermocyclers; next generation sequencing split between long read and short read strategies that enable both comprehensive pathogen discovery and targeted surveillance; and polymerase chain reaction platforms differentiated into digital PCR and real-time PCR formats that continue to set benchmarks for analytical sensitivity.

Animal type segmentation directs where kit performance and usability matter most, with aquaculture applications focused on fish and shrimp diagnostics that contend with unique sampling matrices; companion animal testing prioritizing cats and dogs in clinical and preventive contexts; livestock diagnostics serving cattle, ovine, and swine populations where herd-level surveillance and rapid herd management decisions are paramount; and poultry diagnostics tailored for chicken, ducks, and turkey operations with high throughput and environmental sampling considerations. End users vary from diagnostic labs-both private and public health laboratories-that demand standardized workflows and regulatory-grade validation, to farms and veterinary clinics that require simple, robust kits for routine screening, to research institutes that need flexible platforms for method development. Sample type specificity drives assay design, with blood matrices divided into plasma, serum, and whole blood; swab-based collection encompassing nasal, oral, and rectal sampling strategies; and fecal and tissue samples requiring specialized extraction protocols. Distribution channels range from direct sales and distributor networks to online platforms, each imposing different requirements for packaging, cold chain logistics, and customer support. Finally, virus type considerations-DNA and RNA pathogens, each with enveloped and non-enveloped subclasses-inform extraction chemistry, assay stability, and biosafety handling protocols. Together, these segmentation dimensions create a mosaic of product requirements that manufacturers must address through targeted design choices, validation strategies, and go-to-market models.

Regional adoption patterns and infrastructure contrasts that determine validation pathways, distribution models, and surveillance collaboration across global veterinary markets

Regional dynamics shape technology adoption curves, regulatory expectations, and supply chain resilience in distinct ways that companies must navigate deliberately. In the Americas, established laboratory networks, strong veterinary infrastructure, and integrated supply channels favor the uptake of high-throughput platforms and validated assay portfolios, while there is simultaneous demand for point-of-care solutions in remote agricultural regions. In Europe, Middle East & Africa, regulatory heterogeneity and varying laboratory capacity create opportunities for flexible validation strategies and modular platforms that can be tailored to local approval pathways and resource constraints. Additionally, the diverse agricultural practices across the region underline the need for adaptable sample collection and training programs.

The Asia-Pacific region presents a dual imperative: high-volume production and intensive aquaculture operations drive demand for scalable diagnostics, while rapid adoption of mobile and decentralized testing favors isothermal and CRISPR-based point-of-care solutions. Regional supply chain hubs in parts of Asia also offer manufacturing and distribution advantages, but they require rigorous quality control to meet exporting nations' regulatory standards. Cross-region collaboration and harmonization efforts are increasingly important, as data sharing and coordinated surveillance enhance early detection and response capabilities across borders.

Profiles of competitive advantage that combine rapid assay innovation, rigorous validation practices, scalable manufacturing, and partnership ecosystems to drive adoption

Competitive dynamics in this sector are shaped less by sheer scale and more by the ability to integrate technical innovation with real-world validation, regulatory clarity, and reliable supply chains. Leading organizations demonstrate capabilities in rapid assay development, robust analytical and clinical validation, and the capacity to scale manufacturing while maintaining stringent quality controls. Partnerships between assay developers, instrument manufacturers, and distribution specialists are commonplace, enabling faster market access and broader service offerings that combine kits with consumables, instrumentation, and digital reporting tools.

In addition, companies that invest in comprehensive field studies, third-party validations, and transparent performance data tend to build greater trust among end users and regulatory bodies. Service-oriented business models that include training, on-site support, and data management services differentiate offerings in markets where technical expertise varies. Strategic collaborations with academic and public health institutions further strengthen credibility and accelerate adoption by demonstrating real-world utility in surveillance and outbreak scenarios. Ultimately, the competitive edge emerges from a balanced focus on innovation, operational excellence, and partnership networks that deliver measurable improvements in diagnostic workflows and animal health outcomes.

Actionable strategic moves for companies to translate diagnostic innovation into resilient supply models, rapid validation, and sustained end-user adoption across diverse environments

Industry leaders should prioritize a set of concrete actions to convert technological promise into sustained field impact. First, investing in modular platforms that support multiple assay chemistries reduces time to market for new targets and provides customers with a future-proofed solution. Second, building regional manufacturing and distribution redundancies mitigates the risk of tariff-induced cost shocks and supply interruptions, while targeted inventory strategies preserve continuity for critical reagents. Third, accelerating validation through well-structured field studies and third-party evaluations enhances credibility and shortens procurement cycles among diagnostic labs and large-scale producers.

Furthermore, companies should develop clear regulatory engagement plans that anticipate regional differences and leverage harmonized data packages wherever possible. Strengthening user experience through simplified workflows, intuitive result interpretation, and integrated digital reporting increases uptake among non-specialist end users. Partnering with training providers and veterinary networks ensures correct use and amplifies the value proposition. Finally, organizations should adopt flexible commercial models-such as bundled services, reagent rental, and outcome-based agreements-that align incentives with customers and foster long-term relationships across the veterinary ecosystem.

Robust mixed-methods research approach combining expert interviews, technical validation synthesis, supply chain mapping, and regulatory analysis to underpin actionable insights

The research underpinning this analysis combines structured primary engagement with secondary evidence synthesis to ensure both depth and practical relevance. Primary research incorporated targeted interviews with veterinary diagnosticians, laboratory directors, farm operations managers, and R&D leaders to capture end-user priorities, validation challenges, and procurement preferences. These qualitative inputs were triangulated with protocol reviews, peer-reviewed literature, and regulatory guidance to map technological readiness levels and validation expectations. Technical performance attributes were evaluated through synthesis of assay validation studies and instrument specifications to assess suitability across sample types and use scenarios.

Secondary research included systematic reviews of scientific publications, patent filings, and public health surveillance announcements to identify innovation trajectories and emergent threats. Supply chain analysis combined supplier mapping, logistics considerations, and policy review to determine factors affecting availability and cost. Throughout, findings were validated via iterative expert consultations and cross-checked against real-world deployment case studies to ensure practical applicability. Quality controls included methodological transparency, source corroboration, and peer review by subject matter experts to support the robustness of conclusions and recommendations.

Integrated diagnostic performance, supply chain resilience, and stakeholder collaboration as the determinative factors for future success in animal health surveillance

The converging pressures of pathogen emergence, technological progress, and shifting trade dynamics require a coordinated response from diagnostic developers, distributors, and end users. Success in the animal virus detection kit sector hinges on the ability to deliver analytically robust assays that are operationally feasible across diverse sample matrices and end-user settings. Equally important is the cultivation of resilient supply chains and adaptable commercial strategies that anticipate policy shifts and regional differences. When paired with rigorous field validation and targeted training, these elements create a compelling value proposition that accelerates adoption and strengthens surveillance systems.

Looking forward, the most effective solutions will be those that integrate high-performance chemistry with accessible workflows, transparent performance data, and digital interoperability. Collaboration across public and private stakeholders will amplify the impact of diagnostics on animal health outcomes and, by extension, on food security and public health. Strategic investments in modular platforms, regional manufacturing, and end-user support will be decisive in determining which organizations lead the next phase of diagnostic innovation and implementation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Virus Detection Kit Market, by Technology

  • 8.1. Cripr Based
    • 8.1.1. Cas12
    • 8.1.2. Cas13
  • 8.2. Enzyme Linked Immunosorbent Assay
    • 8.2.1. Competitive
    • 8.2.2. Indirect
    • 8.2.3. Sandwich
  • 8.3. Loop Mediated Isothermal Amplification
    • 8.3.1. Lateral Flow LAMP
    • 8.3.2. Real Time LAMP
  • 8.4. Next Generation Sequencing
    • 8.4.1. Long Read
    • 8.4.2. Short Read
  • 8.5. Polymerase Chain Reaction
    • 8.5.1. Digital PCR
    • 8.5.2. Real Time PCR

9. Animal Virus Detection Kit Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animals
    • 9.2.1. Cats
    • 9.2.2. Dogs
  • 9.3. Livestock
    • 9.3.1. Cattle
    • 9.3.2. Ovine
    • 9.3.3. Swine
  • 9.4. Poultry
    • 9.4.1. Chicken
    • 9.4.2. Ducks
    • 9.4.3. Turkey

10. Animal Virus Detection Kit Market, by Sample Type

  • 10.1. Blood
    • 10.1.1. Plasma
    • 10.1.2. Serum
    • 10.1.3. Whole Blood
  • 10.2. Fecal
  • 10.3. Swab
    • 10.3.1. Nasal
    • 10.3.2. Oral
    • 10.3.3. Rectal
  • 10.4. Tissue

11. Animal Virus Detection Kit Market, by Virus Type

  • 11.1. DNA
    • 11.1.1. Enveloped
    • 11.1.2. Non Enveloped
  • 11.2. RNA
    • 11.2.1. Enveloped
    • 11.2.2. Non Enveloped

12. Animal Virus Detection Kit Market, by End User

  • 12.1. Diagnostic Labs
    • 12.1.1. Private Labs
    • 12.1.2. Public Health Labs
  • 12.2. Farms
  • 12.3. Research Institutes
  • 12.4. Veterinary Clinics

13. Animal Virus Detection Kit Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Platforms

14. Animal Virus Detection Kit Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Animal Virus Detection Kit Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Virus Detection Kit Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Animal Virus Detection Kit Market

18. China Animal Virus Detection Kit Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Agilent Technologies, Inc.
  • 19.7. Bio-Rad Laboratories, Inc.
  • 19.8. Danaher Corporation
  • 19.9. Heska Corporation
  • 19.10. Luminex Corporation
  • 19.11. Merck KGaA
  • 19.12. Neogen Corporation
  • 19.13. PerkinElmer, Inc.
  • 19.14. QIAGEN N.V.
  • 19.15. Roche Diagnostics International AG
  • 19.16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS12, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CAS13, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPETITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY INDIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SANDWICH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LATERAL FLOW LAMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME LAMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LONG READ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHORT READ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FISH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY OVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CHICKEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DUCKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FECAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RECTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NON ENVELOPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PRIVATE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY PUBLIC HEALTH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SWAB, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY VIRUS TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY CRIPR BASED, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 304. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST ANIMAL VIRUS DETECTION KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. MIDDLE EA